Illumina Inc (ILMN)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.91 (-0.65%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Illumina Inc (ILMN)
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Key Insights

Critical company metrics and information
  • Share Price

    $141.09
  • Market Cap

    $22.38 Billion
  • Total Outstanding Shares

    158.60 Million Shares
  • Total Employees

    9,300
  • Dividend

    No dividend
  • IPO Date

    July 28, 2000
  • SIC Description

    Laboratory Analytical Instruments
  • Homepage

    https://www.illumina.com

Historical Stock Splits

If you bought 1 share of ILMN before September 23, 2008, you'd have 2 shares today.
Execution DateSplit Amount
September 23, 20082-for-1

Cash Flow Statement

September 30, 2023 to September 29, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-215.00 Million
Net Cash Flow From Financing Activities, Continuing$-550.00 Million
Net Cash Flow$-58.00 Million
Net Cash Flow From Operating Activities$697.00 Million
Net Cash Flow From Financing Activities$-550.00 Million
Net Cash Flow From Operating Activities, Continuing$697.00 Million
Net Cash Flow From Investing Activities$-215.00 Million
Exchange Gains/Losses$10.00 Million
Net Cash Flow, Continuing$-68.00 Million

Income Statement

September 30, 2023 to September 29, 2024
MetricValue
Net Income/Loss$-1.59 Billion
Benefits Costs and Expenses$5.92 Billion
Research and Development$1.25 Billion
Gross Profit$2.81 Billion
Cost Of Revenue$1.58 Billion
Basic Average Shares$159.00 Million
Diluted Earnings Per Share$9.96
Nonoperating Income/Loss$-361.00 Million
Operating Expenses$3.98 Billion
Net Income/Loss Available To Common Stockholders, Basic$-1.59 Billion
Basic Earnings Per Share$9.95
Selling, General, and Administrative Expenses$1.30 Billion
Income/Loss From Continuing Operations After Tax$-1.59 Billion
Diluted Average Shares$159.00 Million
Costs And Expenses$5.92 Billion
Income Tax Expense/Benefit$52.00 Million
Other Operating Expenses$1.43 Billion
Income/Loss From Continuing Operations Before Tax$-1.54 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Operating Income/Loss$-1.17 Billion
Net Income/Loss Attributable To Parent$-1.59 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Revenues$4.39 Billion

Balance Sheet

September 30, 2023 to September 29, 2024
MetricValue
Equity Attributable To Noncontrolling Interest$0.00
Current Assets$2.37 Billion
Intangible Assets$305.00 Million
Assets$6.01 Billion
Liabilities$3.89 Billion
Wages$237.00 Million
Equity$2.13 Billion
Noncurrent Assets$3.64 Billion
Other Non-current Assets$2.50 Billion
Liabilities And Equity$6.01 Billion
Equity Attributable To Parent$2.13 Billion
Current Liabilities$975.00 Million
Accounts Payable$191.00 Million
Fixed Assets$832.00 Million
Noncurrent Liabilities$2.91 Billion
Other Current Liabilities$547.00 Million
Inventory$574.00 Million
Other Current Assets$1.80 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.